Screener
Cytek Biosciences, Inc. CTKB Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Cytek Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053496
FAQ
- What is Cytek Biosciences, Inc.'s gross margin?
- Cytek Biosciences, Inc. (CTKB) reported gross margin of 53.2% in Q2 2026.
- How has Cytek Biosciences, Inc.'s gross margin changed year-over-year?
- Cytek Biosciences, Inc.'s gross margin decreased by 2.2% year-over-year, from 54.4% to 53.2%.
- What is the long-term trend for Cytek Biosciences, Inc.'s gross margin?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s gross margin has grown at a -1.4% compound annual growth rate (CAGR), from 55.7% to 51.8%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Cytek Biosciences, Inc.'s gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude